3-51361872-A-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_004947.5(DOCK3):​c.5020A>T​(p.Met1674Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00145 in 1,613,104 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0015 ( 2 hom. )

Consequence

DOCK3
NM_004947.5 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:2B:1

Conservation

PhyloP100: 3.25

Publications

5 publications found
Variant links:
Genes affected
DOCK3 (HGNC:2989): (dedicator of cytokinesis 3) This gene is specifically expressed in the central nervous system (CNS). It encodes a member of the DOCK (dedicator of cytokinesis) family of guanine nucleotide exchange factors (GEFs). This protein, dedicator of cytokinesis 3 (DOCK3), is also known as modifier of cell adhesion (MOCA) and presenilin-binding protein (PBP). The DOCK3 and DOCK1, -2 and -4 share several conserved amino acids in their DHR-2 (DOCK homology region 2) domains that are required for GEF activity, and bind directly to WAVE proteins [Wiskott-Aldrich syndrome protein (WASP) family Verprolin-homologous proteins] via their DHR-1 domains. The DOCK3 induces axonal outgrowth in CNS by stimulating membrane recruitment of the WAVE complex and activating the small G protein Rac1. This gene is associated with an attention deficit hyperactivity disorder-like phenotype by a complex chromosomal rearrangement. [provided by RefSeq, Aug 2010]
DOCK3 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008375734).
BP6
Variant 3-51361872-A-T is Benign according to our data. Variant chr3-51361872-A-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 547977.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DOCK3NM_004947.5 linkc.5020A>T p.Met1674Leu missense_variant Exon 48 of 53 ENST00000266037.10 NP_004938.1 Q8IZD9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DOCK3ENST00000266037.10 linkc.5020A>T p.Met1674Leu missense_variant Exon 48 of 53 1 NM_004947.5 ENSP00000266037.8 Q8IZD9

Frequencies

GnomAD3 genomes
AF:
0.00127
AC:
193
AN:
152118
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00295
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00185
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00126
AC:
309
AN:
246018
AF XY:
0.00147
show subpopulations
Gnomad AFR exome
AF:
0.000195
Gnomad AMR exome
AF:
0.00114
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000373
Gnomad NFE exome
AF:
0.00174
Gnomad OTH exome
AF:
0.00117
GnomAD4 exome
AF:
0.00147
AC:
2152
AN:
1460868
Hom.:
2
Cov.:
31
AF XY:
0.00150
AC XY:
1089
AN XY:
726684
show subpopulations
African (AFR)
AF:
0.000239
AC:
8
AN:
33472
American (AMR)
AF:
0.000896
AC:
40
AN:
44654
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26090
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39678
South Asian (SAS)
AF:
0.00200
AC:
172
AN:
86002
European-Finnish (FIN)
AF:
0.000562
AC:
30
AN:
53366
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5758
European-Non Finnish (NFE)
AF:
0.00161
AC:
1788
AN:
1111500
Other (OTH)
AF:
0.00184
AC:
111
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
125
250
374
499
624
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00127
AC:
193
AN:
152236
Hom.:
0
Cov.:
33
AF XY:
0.00132
AC XY:
98
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.000289
AC:
12
AN:
41544
American (AMR)
AF:
0.00294
AC:
45
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4826
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00185
AC:
126
AN:
68002
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
11
21
32
42
53
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00162
Hom.:
0
Bravo
AF:
0.00108
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00165
AC:
14
ExAC
AF:
0.00128
AC:
155
EpiCase
AF:
0.00224
EpiControl
AF:
0.00154

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 30, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DOCK3: PM3, PM2:Supporting, BP4 -

Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia Pathogenic:1
Aug 13, 2020
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
18
DANN
Benign
0.69
DEOGEN2
Benign
0.091
T
Eigen
Benign
-0.20
Eigen_PC
Benign
0.022
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.88
D
M_CAP
Benign
0.0013
T
MetaRNN
Benign
0.0084
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.055
N
PhyloP100
3.2
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-0.47
N
REVEL
Benign
0.076
Sift
Benign
1.0
T
Sift4G
Benign
0.52
T
Polyphen
0.0
B
Vest4
0.15
MutPred
0.22
Loss of MoRF binding (P = 0.0723);
MVP
0.21
MPC
0.45
ClinPred
0.034
T
GERP RS
5.3
Varity_R
0.38
gMVP
0.076
Mutation Taster
=34/66
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142515812; hg19: chr3-51399303; API